Capital Analysts, LLC Omeros Corp Transaction History

Capital Analysts, LLC

$2.26 Billion
Q2 2024

A detailed history of Capital Analysts, LLC transactions in Omeros Corp stock. As of the latest transaction made, Capital Analysts, LLC holds 1,000 shares of OMER stock, worth $3,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000

Previous 1,000 -0.0%

Holding current value

$3,970

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$14.81 - $19.13 $14,810 - $19,130	-1,000 Reduced 50.0%	1,000 $15,000
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $29,040 - $47,060	2,000 New	2,000 $36,000
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $1.2 Million - $1.8 Million	-118,767 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$9.57 - $21.32 $427,798 - $953,046	44,702 Added 60.36%	118,767 $1.2 Million
Q2 2020 Aug 07, 2020	SELL	$12.21 - $16.99 $4,578 - $6,371	-375 Reduced 0.5%	74,065 $1.09 Million
Q1 2020 May 08, 2020	BUY	$9.03 - $19.72 $4,018 - $8,775	445 Added 0.6%	74,440 $995,000
Q4 2019 Feb 12, 2020	BUY	$13.01 - $17.15 $910 - $1,200	70 Added 0.09%	73,995 $1.04 Million
Q4 2018 Feb 13, 2019	BUY	$10.72 - $16.73 $124,888 - $194,904	11,650 Added 18.71%	73,925 $824,000
Q3 2018 Nov 07, 2018	BUY	$17.73 - $26.69 $10,638 - $16,014	600 Added 0.97%	62,275 $0
Q2 2018 Aug 03, 2018	SELL	$10.79 - $24.44 $2,967 - $6,721	-275 Reduced 0.44%	61,675 $0
Q1 2018 May 14, 2018	BUY	$9.0 - $20.16 $18,000 - $40,320	2,000 Added 3.34%	61,950 $692,000
Q4 2017 Feb 14, 2018	SELL	$13.26 - $22.86 $7.04 Million - $12.1 Million	-530,899 Reduced 89.85%	59,950 $1.17 Million
Q4 2017 Feb 12, 2018	BUY	$13.26 - $22.86 $7.04 Million - $12.1 Million	530,899 Added 885.57%	590,849 $36.1 Million
Q3 2017 Nov 06, 2017	BUY	$19.76 - $24.9 $1.18 Million - $1.49 Million	59,950	59,950 $1.3 Million

Others Institutions Holding OMER

# of Institutions

112

Shares Held

25.5M

Call Options Held

317K

Put Options Held

556K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $249M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Omeros Corp Transaction History